Trademark: 86119892
Word
RNART
Status
Registered
Status Code
705
Status Date
Saturday, July 10, 2021
Serial Number
86119892
Registration Number
4694261
Registration Date
Tuesday, March 3, 2015
Mark Type
4000
Filing Date
Friday, November 15, 2013
Published for Opposition
Tuesday, December 16, 2014

Trademark Owner History
CUREVAC SE -
CUREVAC AG -
CureVac GmbH - Original Registrant

Classifications
5 CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERINARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMORS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE
1 Chemical products and biomolecules, namely, biological macromolecules used for industrial and scientific purposes; reagents for research use
44 [ MEDICAL AND VETERINARY MEDICAL SERVICES, namely, THERAPEUTIC AND PREVENTIVE TREATMENT OF TUMORS, INFECTIOUS OR AUTOIMMUNE DISEASES AND ALLERGIES; TREATMENT OF HERITABLE DISEASES; MEDICAL SERVICES IN THE NATURE OF MEDICAL THERAPIES REPLACING PROTEINS OR ENZYMES; TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES; AND TREATMENT OF METABOLIC DISEASES ]
42 Scientific and technological services and research work, namely, the identification and characterization of biological macromolecules

Trademark Events
Mar 3, 2024
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Mar 8, 2023
Automatic Update Of Assignment Of Ownership
Jul 10, 2021
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jul 10, 2021
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jul 10, 2021
Case Assigned To Post Registration Paralegal
Mar 1, 2021
Teas Section 8 & 15 Received
Mar 3, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 12, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 12, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 23, 2016
Automatic Update Of Assignment Of Ownership
Mar 3, 2015
Registered-Principal Register
Dec 16, 2014
Official Gazette Publication Confirmation E-Mailed
Dec 16, 2014
Published For Opposition
Nov 26, 2014
Notification Of Notice Of Publication E-Mailed
Nov 10, 2014
Law Office Publication Review Completed
Nov 4, 2014
Assigned To Lie
Nov 4, 2014
Assigned To Lie
Oct 20, 2014
Approved For Pub - Principal Register
Sep 24, 2014
Amendment From Applicant Entered
Sep 24, 2014
Correspondence Received In Law Office
Sep 17, 2014
Assigned To Lie
Sep 15, 2014
Paper Received
Mar 10, 2014
Notification Of Non-Final Action E-Mailed
Mar 10, 2014
Non-Final Action E-Mailed
Mar 10, 2014
Non-Final Action Written
Mar 4, 2014
Assigned To Examiner
Nov 30, 2013
New Application Office Supplied Data Entered
Nov 19, 2013
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24